MarketPeel
Insider Trading Intelligence
KS

Karimah Es Sabar

CAPR
DIRECTOR · CAPRICOR THERAPEUTICS, INC. · CIK 0001873796
FILING MIX · LIFETIME71%/29%
BUYS
15
SELLS
6
TOTAL VALUE
$4.34M
COMPANIES
1
ACTIVE SINCE
Jul 2021
HOLDINGS NOW
0
AVG SELL PX
$30.66
TRADE KIND
SHOWING 21 / 21
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 9 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Karimah Es Sabar, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+33.33%+2.84%+2.74%+0.10%+1.74%
14d3+0.00%+12.76%+6.87%+5.89%+7.43%
30d3+33.33%+3.12%+10.12%-7.01%-7.36%
60d3+100.00%-3.82%
90d3+100.00%-19.47%+13.02%-32.49%-33.31%
180d3(3 pending)
1y3(3 pending)
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CAPR · 0 shares · as of Apr 2, 2026
028,75057,50086,250115,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 6 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
7,529161Apr 2, 2026Apr 3, 2026View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
7,529$3.18$23.9K7,529Apr 2, 2026Apr 3, 2026View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,529$32.00$240.9K0Apr 2, 2026Apr 3, 2026View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
53,735$4.86$261.2K53,735Apr 1, 2026Apr 1, 2026View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
53,735$31.03$1.67M0Apr 1, 2026Apr 1, 2026View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
53,7350Apr 1, 2026Apr 1, 2026View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
61,265$30.17$1.85M0Mar 31, 2026Apr 1, 2026View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
61,26553,735Mar 31, 2026Apr 1, 2026View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
61,265$4.86$297.7K61,265Mar 31, 2026Apr 1, 2026View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,50015,500Jan 5, 2026Jan 7, 2026View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,94011,940Jan 2, 2025Jan 6, 2025View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,7505,750Jan 2, 2025Jan 6, 2025View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,5202,520Jan 2, 2025Jan 6, 2025View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,4604,460Jan 2, 2024Jan 4, 2024View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
29,25029,250Jan 2, 2024Jan 4, 2024View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,28014,280Jan 2, 2024Jan 4, 2024View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,5603,560Jan 3, 2023Jan 6, 2023View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
37,77037,770Jan 3, 2023Jan 5, 2023View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,00019,000Jan 3, 2023Jan 5, 2023View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,6907,690Jan 3, 2022Jan 4, 2022View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
115,000115,000Jul 23, 2021Jul 27, 2021View →
Other insiders · CAPR
Loading peer insiders…
About this filer
CIK 0001873796
ROLE
Director
PRIMARY
CAPR
COMPANIES
1
ACTIVE SINCE
Jul 2021
MARKETPEEL · /INSIDER/0001873796DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback